VIV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
VIV is not a good buy right now for an impatient investor. The primary trend is still bullish (stacked moving averages), but the setup is stretched/overbought (RSI 70) and momentum is cooling (MACD histogram still positive but contracting) while the stock sits below near-term resistance (14.47). With no Intellectia buy signals today and a fresh bearish analyst re-initiation citing stretched valuation after a strong run, the risk/reward for an immediate entry is not attractive versus waiting for a pullback toward the pivot/support zone.
Price action: Closed at 14.10 (-1.87%), slightly below the options snapshot price (~14.18), under near-term resistance R1 at 14.471 but above the pivot at 13.425. Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200 (uptrend intact). Momentum: MACD histogram 0.205 (above zero) but positively contracting, implying upside momentum is weakening. RSI: RSI_6 at 70.289 indicates overbought/extended conditions (despite the provided label calling it “neutral,” the level is typically overbought). Key levels: Support/pullback area = pivot 13.425 (then S1 12.378). Resistance = 14.471 (R1) then 15.118 (R2). Pattern-based forward odds: Modest upside bias from similar patterns (+0.22% next day, +1.26% next week, +1.08% next month) but not a strong edge.
Intellectia Proprietary Trading Signals
Q3 2025 fundamentals strengthened: revenue +8.40% YoY, net income +15.29% YoY, EPS +22.22% YoY; gross margin improved to 45.52% (+2.36% YoY), supporting the ongoing uptrend.
Options market skew is strongly bullish (call-heavy OI/volume).
Technicals remain in an uptrend (bullish moving-average stack).
Near-term technical stretch: RSI ~70 and MACD momentum is fading, raising the odds of consolidation/pullback rather than a clean breakout.
Overhead resistance nearby at ~14.47; price is currently below it after a down day.
Analyst pushback on valuation: BofA reinstated coverage with Underperform and $14 target, explicitly calling valuation “stretched” after the strong 2025 run.
No news/event catalysts in the last week to drive a fresh upside impulse.
No notable hedge fund/insider trend signals recently (both neutral).
Latest reported quarter: 2025/Q3. Growth trend: Positive and accelerating on earnings—Revenue 2.744B (+8.40% YoY), Net Income 346.65M (+15.29% YoY), EPS 0.11 (+22.22% YoY). Profitability: Gross margin expanded to 45.52% (+2.36% YoY), indicating improving operating quality rather than purely top-line growth.
Recent trend (VIV-specific): Mixed.
